A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.

Andreas Vychytil; Rebecca Herzog; Paul Probst; Werner Ribitsch; Karl Lhotta; Veronika Machold-Fabrizii; Martin Wiesholzer; Michaela Kaufmann; Hermann Salmhofer; Martin Windpessl; Alexander R Rosenkranz; Rainer Oberbauer; Franz König; Klaus Kratochwill; Christoph Aufricht

doi:10.1016/j.kint.2018.08.031

A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.

Andreas Vychytil
, Rebecca Herzog
, Paul Probst
, Werner Ribitsch
, Karl Lhotta
, Veronika Machold-Fabrizii
, Martin Wiesholzer
, Michaela Kaufmann
, Hermann Salmhofer (Co-Autor/-in)
, Martin Windpessl
, Alexander R Rosenkranz
, Rainer Oberbauer
, Franz König
, Klaus Kratochwill
, Christoph Aufricht

Universitätsklinik für Innere Medizin 1 - Gastroenterologie- Hepatologie, Nephrologie, Stoffwechsel und Diabetologie

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

41 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	1227-1237
Fachzeitschrift	KIDNEY INTERNATIONAL
Jahrgang	94
Ausgabenummer	6
DOIs	https://doi.org/10.1016/j.kint.2018.08.031
Publikationsstatus	Veröffentlicht - 2018

Zugriff auf Dokument

10.1016/j.kint.2018.08.031

Dieses zitieren

Vychytil, A., Herzog, R., Probst, P., Ribitsch, W., Lhotta, K., Machold-Fabrizii, V., Wiesholzer, M., Kaufmann, M., Salmhofer, H., Windpessl, M., Rosenkranz, A. R., Oberbauer, R., König, F., Kratochwill, K., & Aufricht, C. (2018). A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health. KIDNEY INTERNATIONAL , 94(6), 1227-1237. https://doi.org/10.1016/j.kint.2018.08.031

Vychytil, Andreas ; Herzog, Rebecca ; Probst, Paul et al. / A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health. in: KIDNEY INTERNATIONAL 2018 ; Jahrgang 94, Nr. 6. S. 1227-1237.

@article{7c01d238472c4a4ab7246bca843f8845,

title = "A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.",

keywords = "CRITICALLY-ILL PATIENTS, MESOTHELIAL CELLS, PARENTERAL-NUTRITION, ALPHA PRODUCTION, CRITICAL ILLNESS, TRAUMA PATIENTS, NEUTRAL-PH, FACTOR-I, EXPRESSION, SURVIVAL",

author = "Andreas Vychytil and Rebecca Herzog and Paul Probst and Werner Ribitsch and Karl Lhotta and Veronika Machold-Fabrizii and Martin Wiesholzer and Michaela Kaufmann and Hermann Salmhofer and Martin Windpessl and Rosenkranz, \{Alexander R\} and Rainer Oberbauer and Franz K{\"o}nig and Klaus Kratochwill and Christoph Aufricht",

note = "Salmhofer: Paracelsus Med Univ, Dept Med 1, Salzburg, Austria; ",

year = "2018",

doi = "10.1016/j.kint.2018.08.031",

language = "English",

volume = "94",

pages = "1227--1237",

journal = "KIDNEY INTERNATIONAL ",

issn = "0085-2538",

number = "6",

}

Vychytil, A, Herzog, R, Probst, P, Ribitsch, W, Lhotta, K, Machold-Fabrizii, V, Wiesholzer, M, Kaufmann, M, Salmhofer, H, Windpessl, M, Rosenkranz, AR, Oberbauer, R, König, F, Kratochwill, K & Aufricht, C 2018, 'A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.', KIDNEY INTERNATIONAL , Jg. 94, Nr. 6, S. 1227-1237. https://doi.org/10.1016/j.kint.2018.08.031

A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health. / Vychytil, Andreas; Herzog, Rebecca; Probst, Paul et al.
in: KIDNEY INTERNATIONAL , Jahrgang 94, Nr. 6, 2018, S. 1227-1237.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.

AU - Vychytil, Andreas

AU - Herzog, Rebecca

AU - Probst, Paul

AU - Ribitsch, Werner

AU - Lhotta, Karl

AU - Machold-Fabrizii, Veronika

AU - Wiesholzer, Martin

AU - Kaufmann, Michaela

AU - Salmhofer, Hermann

AU - Windpessl, Martin

AU - Rosenkranz, Alexander R

AU - Oberbauer, Rainer

AU - König, Franz

AU - Kratochwill, Klaus

AU - Aufricht, Christoph

N1 - Salmhofer: Paracelsus Med Univ, Dept Med 1, Salzburg, Austria;

PY - 2018

Y1 - 2018

KW - CRITICALLY-ILL PATIENTS

KW - MESOTHELIAL CELLS

KW - PARENTERAL-NUTRITION

KW - ALPHA PRODUCTION

KW - CRITICAL ILLNESS

KW - TRAUMA PATIENTS

KW - NEUTRAL-PH

KW - FACTOR-I

KW - EXPRESSION

KW - SURVIVAL

U2 - 10.1016/j.kint.2018.08.031

DO - 10.1016/j.kint.2018.08.031

M3 - Original Article

C2 - 30360960

SN - 0085-2538

VL - 94

SP - 1227

EP - 1237

JO - KIDNEY INTERNATIONAL

JF - KIDNEY INTERNATIONAL

IS - 6

ER -

Vychytil A, Herzog R, Probst P, Ribitsch W, Lhotta K, Machold-Fabrizii V et al. A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health. KIDNEY INTERNATIONAL . 2018;94(6):1227-1237. doi: 10.1016/j.kint.2018.08.031